Skip to main content
SpringerLink
Log in

Oral Mucosa Signs of Immune, Autoimmune, and Rheumatic Diseases

  • Chapter
Oral Diseases

  • 790 Accesses

Abstract

Systemic slcerosis, scleroderma.

This is a generalized multisystem autoimmune disease characterized by proliferative microcirculatory change leading to fibrosis of skin, lung, heart, kidney, and gastrointestinal tract.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Black CM. The etiopathogenesis of systemic sclerosis. J Int Med 1993; 234:3–8

    Article  CAS  Google Scholar 

  2. Foster TD, Fairburn EA. Dental involvement in scleroderma. Br Dent J 1968; 124:353–56

    PubMed  CAS  Google Scholar 

  3. Rowell NR, Hopper FE. The periodontal membrane in systemic sclerosis. Br J Dermatol 1977; 96:15–20

    Article  PubMed  CAS  Google Scholar 

  4. Andreasen JA. Oral manifestations in discoid and systemic lupus erythematosus. Acta Odontol Scand 1964; 22:295–310

    Article  PubMed  CAS  Google Scholar 

  5. Schiodt M, Halberg P, Hentzer B. A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg 1978; 7:85–94

    Article  PubMed  CAS  Google Scholar 

  6. Urmann JD, Lowenstein MB, Abeles M, Weinstein A. Oral mucosal ulceration in systemic lupus erythematosus. Arthritis Rheum 1978; 21:58–61

    Article  Google Scholar 

  7. SchiØdt M. Oral manifestations of lupus erythematosus. Int J Oral Surg 1984; 13:101–105

    Article  PubMed  Google Scholar 

  8. SchiØdt M, Pindborg JJ. Oral discoid lupus erythematosus. I. The validity of previous histopathologic diagnostic criteria. Oral Surg 1984; 57:46–51

    Article  PubMed  Google Scholar 

  9. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981; 4:471–475

    Article  PubMed  CAS  Google Scholar 

  10. Callen JP. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad Dermatol 1985; 12:278–288

    Article  PubMed  CAS  Google Scholar 

  11. Callen JP, Tuffanelli DL, Provost TT. Collagen-vascular disease. An update. J Am Acad Dermatol 1993; 28:477–484

    Article  PubMed  CAS  Google Scholar 

  12. Alarcon Segovia D. Mixed connective tissue disease. Clin Dermatol 1994; 12:309–316

    Article  Google Scholar 

  13. Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand 1967; 25 suppl 49

    Google Scholar 

  14. Moutsopoulos HM, Kordossis T. Sjoegren syndrome revisited: autoimmune epithelitis. Br J Rheumatol 1996; 35:204–206

    Article  PubMed  CAS  Google Scholar 

  15. Schuermann H, Greither A, Hornstein O. Krankheiten der Mundschleimhaut und der Lippen. 3. Aufl. Munich: Urban and Schwarzenberg, 1966; 239–240, 305–307

    Google Scholar 

  16. Medseger TA, Oddis CV. Inflammatory muscle disease: clinical features. In: Klippel JH, Dieppe PA (Eds). Rheumatology. London: Mosby, 1994; 12.1–12.14

    Google Scholar 

  17. Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 1991; 30:307–12

    Article  PubMed  CAS  Google Scholar 

  18. Thivolet J. Pemphigus: past, present and future. Dermatology 1994; 189 (Suppl 2):26–9

    Article  PubMed  Google Scholar 

  19. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin 1993; 11:429–52

    PubMed  CAS  Google Scholar 

  20. Korman NJ. Pemphigus. Dermatol Clin 1990; 8:689–700

    PubMed  CAS  Google Scholar 

  21. Niizeki H, Inoko H, Mizuki N, et al. HLA-DQA1, DQβ1and DRβ1genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method. Tissue Antigens 1994;44:248–51

    Article  PubMed  CAS  Google Scholar 

  22. Matzner Y, Erlich HA, Brautbar C, et al. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm Venereol (Stockh) 1995; 75:12–4

    CAS  Google Scholar 

  23. Moraes JR, Moraes ME, Gernadez Vina M, et al. HLA antigens and the risk of development of pemphigus foliaceus (“fogo selvage”) in endemic areas of Brazil. Immunogenetics 1991; 33:388–91

    Article  PubMed  CAS  Google Scholar 

  24. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323:1729–35

    Article  PubMed  CAS  Google Scholar 

  25. Amagai M. Adhesion molecules. I: Keratinocyte-keratinocyte interactions; Cadherins and pemphigus. J Invest Dermatol 1995; 104:146–52

    Article  PubMed  CAS  Google Scholar 

  26. Bystryn JC. Therapy of pemphigus. Semin Dermatol 1988; 7:186–94

    PubMed  CAS  Google Scholar 

  27. Aberer W, Wolff-Schreiner EC, Stingl G, et al. Azathioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol 1987; 16:527–33

    Article  PubMed  CAS  Google Scholar 

  28. Sondergaard K, Carstens J, Jorgensen J, Zachariae H. The steroid-sparing effect of long-term plasmapheresis in pemphigus. Acta Derm Venereol 1995; 75:150–2

    PubMed  CAS  Google Scholar 

  29. Barthelemy H, Frappaz A, Cambazard F, et al. Treatment of nine cases of pemphigus vulgaris with cyclosporine. J Am Acad Dermatol 1988; 18:1262–6

    Article  PubMed  CAS  Google Scholar 

  30. Rook AH, Jegasothy BV, Heald P, et al. Extracorporeal photo-chemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990; 112:303–5

    PubMed  CAS  Google Scholar 

  31. Smith EP, Zone JJ. Dermatitis herpetiformis and linear IgA bullous dermatosis. Dermatol Clin 1993; 11:511–26

    PubMed  CAS  Google Scholar 

  32. Hall III RP. Dermatitis herpetiformis. J Invest Dermatol 1992; 99:873–81

    Article  PubMed  Google Scholar 

  33. Hall III RP, Otley C. Immunogenetics of dermatitis herpetiformis. Semin Dermatol 1991; 10:240–5

    PubMed  Google Scholar 

  34. Otley C, Hall III RP. Dermatitis herpetiformis. Dermatol Clin 1990; 8:759–69

    PubMed  CAS  Google Scholar 

  35. Katz SI. Dermatitis herpetiformis. Clinical, histologic, therapeutic and laboratory clues. Int J Dermatol 1978; 17:529–35

    Article  PubMed  CAS  Google Scholar 

  36. Fraser NG, Kerr NW, Donald D. Oral lesions in dermatitis herpetiformis. Br J Dermatol 1973; 89:439–50

    Article  PubMed  CAS  Google Scholar 

  37. Economopoulou P, Laskaris G. Dermatitis herpetiformis: oral lesions as an early manifestation. Oral Surg Oral Med Oral Pathol 1986; 62:77–80

    Article  PubMed  CAS  Google Scholar 

  38. Ahmed AR, Hameed A. Bullous pemphigoid and dermatitis herpetiformis. Clin Dermatol 1993; 11:47–52

    Article  PubMed  CAS  Google Scholar 

  39. Chorzelski TP, Jablonska S, Maciejowska E. Linear IgA bullous dermatosis of adults. Clin Dermatol 1992; 9:383–92

    Article  Google Scholar 

  40. Jablonska S, Chorzelski TP, Rosinska D, Maciejowska E. Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol 1992; 9:393–401

    Article  Google Scholar 

  41. Smith EP, Zone JJ. Dermatitis herpetiformis and linear IgA bullous dermatosis. Dermatol Clin 1993; 11:511–26

    PubMed  CAS  Google Scholar 

  42. McEvoy MT, Connolly SM. Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol 1990; 22:59–63

    Article  PubMed  CAS  Google Scholar 

  43. Smith JB, Hogan DJ. Factors that exacerbate linear IgA disease (Correspondence). J Am Acad Dermatol (Correspondence) 1995; 33:320–21

    Article  CAS  Google Scholar 

  44. Prost C, De Leca AC, Combemale P, et al. Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. J Invest Dermatol 1989; 92:39–45

    Article  PubMed  CAS  Google Scholar 

  45. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 1988; 119:161–70

    Article  PubMed  CAS  Google Scholar 

  46. Wojnarowska F, Collier PM, Allen J, Millard PR. The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used. Br J Dermatol 1995; 132:750–7

    Article  PubMed  CAS  Google Scholar 

  47. Chan LS, Regezi JA, Cooper KD. Oral manifestations of linear IgA disease. J Am Acad Dermatol 1990; 22:362–5

    Article  PubMed  CAS  Google Scholar 

  48. Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992; 27:79–87

    Article  PubMed  CAS  Google Scholar 

  49. Flowers FP, Sherertz EF. Immunologic disorders of the skin and mucous membranes. Med Clin N Am 1985; 69:657–73

    PubMed  CAS  Google Scholar 

  50. Gately III LE, Nesbitt LT. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin 1994; 12:133–42.

    Article  PubMed  Google Scholar 

  51. Anhalt GJ. Pemphigoid. Bullous and cicatricial. Dermatol Clin 1990; 8:701–16

    PubMed  CAS  Google Scholar 

  52. Korman NJ. Bullous pemphigoid. Dermatol Clin 1993; 11:483–98

    PubMed  CAS  Google Scholar 

  53. Ahmed AR, Hameed A. Bullous pemphigoid and dermatitis herpetiformis. Clin Dermatol 1993; 11:47–52

    Article  PubMed  CAS  Google Scholar 

  54. Hopkinson SB, Baker SE, Jones JCR. Molecular genetic studies of human epidermal autoantigen (the 180-kd bullous pemphigoid antigen/BP 180): identification of functionally important sequences within the BP 180 molecule and evidence for an interaction between BP 180 and a6integrin. J Cell Biol 1995; 130:117–25

    Article  PubMed  CAS  Google Scholar 

  55. Liu Z, Giudice GJ, Swartz SJ, et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95:1539–44

    Article  PubMed  CAS  Google Scholar 

  56. Shklar G, Meyer I, Zacarian SA. Oral lesions in bullous pemphigoid. Arch Dermatol 1969; 99:663–70

    Article  PubMed  CAS  Google Scholar 

  57. Venning VA, Frith PA, Baron AJ, Millard RP, Wojnarowska F. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988;118:7–15

    Article  PubMed  CAS  Google Scholar 

  58. Person JR, Rogers RS. Bullous and cicatricial pemphigoid. Clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc 1977; 52:54–66

    PubMed  CAS  Google Scholar 

  59. Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992; 27:79–87

    Article  PubMed  CAS  Google Scholar 

  60. Flowers FP, Sherertz EF. Immunologic disorders of the skin and mucous membranes. Med Clin N Am 1985; 69:657–73

    PubMed  CAS  Google Scholar 

  61. Gately LE, Nesbitt LT. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin 1994; 12:133–42

    Article  PubMed  Google Scholar 

  62. Chan LS, Yancey KB, Hammerberg C, et al. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Arch Dermatol 1993; 129:448–55

    Article  PubMed  CAS  Google Scholar 

  63. Pereyo NG, Davis LS. Generalized bullous pemphigoid controlled by tetracycline therapy alone. J Am Acad Dermatol 1995; 32:138–9

    Article  PubMed  CAS  Google Scholar 

  64. Ahmed AR, Kurgis BS, Rogers III RS. Cicatricial pemphigoid. J Am Acad Dermatol 1991; 24:987–1001

    Article  PubMed  CAS  Google Scholar 

  65. Mutasim DF, Pelc NJ, Anhalt GJ. Cicatricial pemphigoid. Dermatol Clin 1993; 11:499–510

    Article  PubMed  CAS  Google Scholar 

  66. Kurzhals G, Stolz W, Maciejewski W, et al. Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid. Report of a case proved by preembedding immunogold electron microscopy. Arch Dermatol 1995; 131:580–5

    Article  PubMed  CAS  Google Scholar 

  67. Yunis JJ, Mobini N, Yunis EJ, et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994;91:7747–51

    Article  PubMed  CAS  Google Scholar 

  68. Bédane C, Prost C, Bernard P, et al. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. J Invest Dermatol 1991; 97:3–9

    Article  PubMed  Google Scholar 

  69. Shimizu H, Masunaga T, Ishiko A, et al. Autoantibodies from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. J Invest Dermatol 1995;104:370–3

    Article  PubMed  CAS  Google Scholar 

  70. Chan LS, Yancey KB, Hammerberg C, et al. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Arch Dermatol 1993; 129:448–55

    Article  PubMed  CAS  Google Scholar 

  71. Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992; 27:79–87

    Article  PubMed  CAS  Google Scholar 

  72. Gately LE, Nesbitt LT. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin 1994; 12:133–42.

    Article  PubMed  Google Scholar 

  73. Shklar G, Meyer I, Zacarian SA. Oral lesions in bullous pemphigoid. Arch Dermatol 1969; 99:663–70

    Article  PubMed  CAS  Google Scholar 

  74. Venning VA, Frith PA, Bron AJ, et al. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988; 118:7–15

    Article  PubMed  CAS  Google Scholar 

  75. Williams DM. Non-infectious diseases of the oral soft tissue: a new approach. Adv Dent Res 1993; 7:213–9

    PubMed  CAS  Google Scholar 

  76. Person JR, Rogers RS. Bullous and cicatricial pemphigoid. Clinical, histopathologic and immunopathologic correlations. Mayo Clin Proc 1977; 52:54–66

    PubMed  CAS  Google Scholar 

  77. Flowers FP, Sherertz EF. Immunologic disorders of the skin and mucous membranes. Med Clin N Am 1985; 69:657–73

    PubMed  CAS  Google Scholar 

  78. Gammon WR, Briggaman RA. Epidermolysis bullosa acquisi-ta and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 1993;11:535–47

    Article  PubMed  CAS  Google Scholar 

  79. Woodley DT, Briggaman RA, Gammon WR. Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin 1990; 8:717–26

    PubMed  CAS  Google Scholar 

  80. Woodley DT, Sarret Y, Briggaman RA. Autoimmunity to type VII collagen. Semin Dermatol 1991; 10:232–9

    PubMed  CAS  Google Scholar 

  81. Gammon WR. Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen. J Autoimmunity 1991; 4:59–71

    Article  CAS  Google Scholar 

  82. Van Joost T, Van’t Veen AJ. Drug induced cicatricial pemphigoid and acquired epidermolysis bullosa. Clin Dermatol 1993; 11:521–7

    Article  PubMed  Google Scholar 

  83. Rubenstein R, Esterly NB, Fine JD. Childhood epidermolysis bullosa acquisita. Arch Dermatol 1987; 123:772–6

    Article  PubMed  CAS  Google Scholar 

  84. Williams DM. Non infectious diseases of the oral soft tissue: a new approach. Adv Dent Res 1993; 7:213–9

    PubMed  CAS  Google Scholar 

  85. Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992; 27:79–87

    Article  PubMed  CAS  Google Scholar 

  86. Flowers FP, Sherertz EF. Immunologic disorders of the skin and mucous membranes. Med Clin N Am 1985; 69:657–73

    PubMed  CAS  Google Scholar 

  87. Gately LE, Nesbitt LT. Update on immunofluorescent testing in bullous diseases and lupus erythematosus. Dermatol Clin 1994; 12:133–42

    Article  PubMed  Google Scholar 

  88. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Oral Surg Oral Med Oral Pathol 1994; 77:555–71

    Article  PubMed  CAS  Google Scholar 

  89. Poulter LW, Lehener T. Immunohistology of oral lesions from patients with recurrent oral ulcers and Behet’s syndrome. Clin Exp Immunol 1989; 78:189–95

    PubMed  CAS  Google Scholar 

  90. Fischman SL. Oral ulcerations. Semin Dermatol 1994; 13:74–7

    PubMed  CAS  Google Scholar 

  91. Pederson A. Recurrent aphthous ulceration: virological and immunological aspects. APMIS 1993; 37:1–37

    Google Scholar 

  92. Boisnic S, Tovaru S. Evaluation and treatment of aphthous ulcerations of the mouth. Ann Dermatol Venereol 1991;118:53–9

    PubMed  CAS  Google Scholar 

  93. Peterson DL, Georghion PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995; 20:250–4

    Article  Google Scholar 

  94. Katz J, Langevitz P, Shermer J, et al. Prevention of recurrent aphthous stomatitis with colchicine: an open trial. J Am Acad Dermatol 1994; 31:459–61

    Article  PubMed  CAS  Google Scholar 

  95. Turnbull RS. Benzydamine hydrochloride (tantum) in the management of oral inflammatory conditions. J Can Dent Assoc 1995; 61:127–34

    PubMed  CAS  Google Scholar 

  96. Fabbri P. Immunodermatologia. Brescia: ISED, 1993: 201

    Google Scholar 

  97. Emmi L, Brugnolo F, Salvati G, Marchione T. Immunopathological aspects of Behcet’s disease. Clin Exp Rheum 1995; 13:687–91

    CAS  Google Scholar 

  98. Aydintug AO, Tokgoz G, D’Cruz DP et al. Antibodies to endothelial cells in Behcet’s disease. Clin Immunol Immunopathol 1993; 67:157–62

    Article  PubMed  CAS  Google Scholar 

  99. James DG. Behcet’s syndrome. N Engl J Med 1979; 301:431–2

    Article  PubMed  CAS  Google Scholar 

  100. Civatte J, Beiaich S. Histopathologic des aphtes cutanes au cours du syndrome de Behcet. Ann Dermatol Syph 1976; 103:135–40

    Google Scholar 

  101. Haim S. The pathogenesis of lesions in Behcet’s disease. Dermatologica 1979; 158:31–7

    Article  PubMed  CAS  Google Scholar 

  102. International Study Group for Behcet’s disease: Criteria for diagnosis of Behcet’s disease. Lancet 1990; 1:1078–80

    Google Scholar 

  103. Yazici H, Pazarli H, Barnes CG, et al. A controlled trial of azathioprine in Behcet’s syndrome. N Engl J Med 1990; 322:281–5

    Article  PubMed  CAS  Google Scholar 

  104. Muftuoglu AU, Pazarli H, Yardakul S et al. Short term cyclosporin-A treatment of Behcet’s disease. Br J Ophthalmol 1987; 71:387–90

    Article  PubMed  CAS  Google Scholar 

  105. Khan MA, van der Linden SM. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 1990; 20:107–13

    Article  PubMed  CAS  Google Scholar 

  106. Schumacher HR. Light and electron microscopic studies on the synovial membrane in Reiter’s syndrome. Immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum 1990; 33:526

    Google Scholar 

  107. Hammer RE. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2m: an animal model of HLA-B27-associated human disorders. Cell 1990;63:1099

    Article  PubMed  CAS  Google Scholar 

  108. Arnet GF. Reiter syndrome: report of case. J Oral Surg 1980; 38:382

    PubMed  CAS  Google Scholar 

  109. Calin A, Fries JF. An “experimental” epidemic of Reiter’s syndrome revisited: follow-up evidence on genetic and environmental factors. Ann Intern Med 1976; 84:564

    PubMed  CAS  Google Scholar 

  110. Calin A. Keratoderma blenorrhagicum and mucocutaneous manifestations of Reiter’s syndrome. Ann Rheum Dis 1979; 38 (suppl): 68–72

    Article  PubMed  Google Scholar 

  111. Dunlop EM. Venereal disease: chlamydial genital infection and its complications. Br J Hosp Med 1983; 29:6–11

    PubMed  CAS  Google Scholar 

  112. Calin A. A placebo controlled crossover study of azothioprine. Ann Rheum Dis 1986; 45:653–35

    Article  PubMed  CAS  Google Scholar 

  113. Chu SM. Reiter’s syndrome, treatment with methotrexate. Singapore Med 1976; 17:101–3

    CAS  Google Scholar 

  114. Yunus MB. Current therapeutic practices in spondyloarthropathies. Compr Ther 1988; 14:54

    PubMed  CAS  Google Scholar 

  115. Valente RM, Conn DL. Influence of pathogenesis on therapeutic choices in systemic vasculitis. Ann Med Interne 1994; 145:517–52

    CAS  Google Scholar 

  116. Gross WL, Hauschild S, Mistry N. The clinical relevance of ANCA in vasculitis. 5th International ANCA Workshop 7–10. 1993

    Google Scholar 

  117. Kallenberg CGM. Autoantibodies in vasculitis: current perspectives. Clin Exp Rheumatol 1993; 11:355–60

    PubMed  CAS  Google Scholar 

  118. Leavitt RY, Fauci AS. Pulmonary vasculitis. Ann Rev Respir Dis 1986; 134:149–154

    CAS  Google Scholar 

  119. Abraham-Inpijn L. Oral and otal manifestations as the primary synptoms in Wegener’s granulomatosis. J Head Neck Pathol 1983; 2:20–2

    Google Scholar 

  120. Israelson H, Binnie WH, Hurt WC. The hyperplastic gingivitis of Wegener’s granulomatosis. J Periodontal 1981; 52:81–7

    CAS  Google Scholar 

  121. Alpern RJ. Southwestern internal medicine conference: vasculitis it’s time to reclassify. Am J Med Sci 1995; 309:235–248

    Article  PubMed  CAS  Google Scholar 

  122. Hoffman GS, Kerr GS, Leavitr RY. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488–98

    PubMed  CAS  Google Scholar 

  123. Najjar T, Gadol C, Khan MY. Immune deficiency with polymorphic reticulosis. Oral Surg 1989; 67:322–6

    Article  PubMed  CAS  Google Scholar 

  124. Sloan P, Fanibunda K, Proctor S. Polymorphic reticulosis with oral lesions: a case report. Br J Oral Surg 1986; 24:426–32

    Article  CAS  Google Scholar 

  125. Crissman JD, Weiss MA, Gluckman J. Midline granuloma syndrome. Aclinicopathologic study of 13 patients. Am J Surg Pathol 1982; 6:335–8

    Article  PubMed  CAS  Google Scholar 

  126. Shehade SA, Foulds IS. Granulomatous cheilitis and a positive Kweim test. Br J Dermatol 1986; 115:619–22

    Article  PubMed  CAS  Google Scholar 

  127. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55:401–12

    Article  PubMed  CAS  Google Scholar 

  128. Worsal N, Christensen KO, Bondensen S et al. Melkersson-Rosenthal syndrome and Crohn’s disease. Br J Oral Surg 1980; 18:254–8

    Article  Google Scholar 

  129. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and the toes in children. Jap J Allergy 1967; 16:178–222

    PubMed  CAS  Google Scholar 

  130. Tizard EJ, Suzuki A, Levin M and Dillon MJ. Clinical aspects of 100 patients with Kawasaki disease. Arch Dis Child 1991; 66:185–88

    Article  PubMed  CAS  Google Scholar 

  131. Rooley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Adv Pediatr 1991; 38:51–74

    Google Scholar 

  132. Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev 1988; 9:209–217

    Article  PubMed  CAS  Google Scholar 

  133. Leung DJM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993,342:1385–1388

    Article  PubMed  CAS  Google Scholar 

  134. Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, Musiani M. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994; 343:1260–1261

    Article  PubMed  CAS  Google Scholar 

  135. Arav-Boger R, Assia A, Jurgenson U, Spirer Z. The immunology of Kawasaki disease. Adv Pediatr 1994; 41:359–67

    PubMed  CAS  Google Scholar 

  136. Rider LG, Wener MH, French J, Sherry DD, Mendelman PM. Autoantibody production in Kawasaki syndrome. Clin Exp Rheumatol 1993; 11:445–449

    PubMed  CAS  Google Scholar 

  137. Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993; 152:309–312

    Article  PubMed  CAS  Google Scholar 

  138. Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease: 4th Revision. Tokyo: Kawasaki Disease. Research Committee, 1984

    Google Scholar 

  139. Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994; 83:1057–1060

    Article  PubMed  CAS  Google Scholar 

  140. Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, American Heart Association. Guidelines for longterm management of patients with Kawasaki disease. Circulation 1994; 89:916–22

    Google Scholar 

  141. Newburger JW. Treatment of Kawasaki disease. Lancet 1996; 347:1128

    Article  PubMed  CAS  Google Scholar 

  142. Salo E, Wangel AG, Pelkonen PI. Intravenous immune globulin reduces the IgG antiendothelial cell antibody response in Kawasaki disease. Endothelium 1993; 1:61–66

    Article  CAS  Google Scholar 

  143. Naughton GK, et al. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81:540

    Article  PubMed  CAS  Google Scholar 

  144. Morohashi M, et al. Ultrastructural studies of vitiligo, Vogt-Koyanagi syndrome, and incontinentia pigmenti achromians. Arch Dermatol 1977; 113:755

    Article  PubMed  CAS  Google Scholar 

  145. Voulot C. Mecanisme de controle de l’extension pigmentaire liee aux autogreffes de la peau. Ann Dermatol Syphiligr (Paris) 1970; 97:549

    CAS  Google Scholar 

  146. Lerner AB. Neural control of pigment cells. In: Kawamura T, et al. (Eds). The biology of normal and abnormal melanocytes. Tokyo: University Park Press, 1971: 3

    Google Scholar 

  147. Miklaszewska M, et al. Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases. Arch Immunol Ther Exp (Warsz) 1972; 20:855

    Google Scholar 

  148. Koh HK, et al. Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study. J Am Acad Dermatol 1983; 9:696

    Article  PubMed  CAS  Google Scholar 

  149. Chapman RS. Coincident vitiligo and psoriasis in the same individual. Arch Dermatol 1973,107:776

    Article  PubMed  CAS  Google Scholar 

  150. Bhawan J, Butain LK. Keratinocyte damage in vitiligo. Cutan Pathol 1983; 10:207

    Article  CAS  Google Scholar 

  151. Lassus A, et al. Treatment of vitiligo with oral methoxsalen and UVA. Photodermatology 1984; 1:170

    PubMed  CAS  Google Scholar 

  152. Lissia M, Luglie PF, Bandettini MV. Lichen planus of oral mucosa: clinical consideration. Ital Gen Rev Dermatol 1988; 25:60–68

    Google Scholar 

  153. Valsecchi R, Bontempelli M, Rossi A, et al. HLA-DR and DQ antigens in lichen planus. Acta Derm Venereol 1988; 68:77–80

    PubMed  CAS  Google Scholar 

  154. Morhenn VB. Etiology of lichen planus. Am J Dermatopathol 1986; 8:154–156

    Article  PubMed  CAS  Google Scholar 

  155. Shioara T, Moriya N, Nagashima M. The lichenoid tissue reaction. Int J Dermatol 1988; 27:365–374

    Article  Google Scholar 

  156. Marder MZ, Deesen KC. Transformation of oral lichen planus to squamous cell carcinoma: a literature review and report of case. J Am Dent Assoc 1982; 105:55–60

    PubMed  CAS  Google Scholar 

  157. Fulling HJ. Cancer development in oral lichen planus. Arch Dermatol 1973; 108:667–669

    Article  PubMed  CAS  Google Scholar 

  158. Firth NA, Reade PC. Angiotensin-Converting enzyme inhibitors implicated in oral mucosa lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989; 67:41–44

    Article  PubMed  CAS  Google Scholar 

  159. Jungell P, Malmstrom M, Wartiovaara J, Konttinen YT. Ultrastructure of oral leukoplakia and lichen planus. I. Basal region and inflammatory cells. J Oral Pathol 1987; 16:170–178

    Article  PubMed  CAS  Google Scholar 

  160. Jungell P. Oral lichen planus: a review. Int J Oral Maxillofac Surg 1991; 20:129–135

    Article  PubMed  CAS  Google Scholar 

  161. Grattan CEH, Boon AP, Gregory J. A preliminary open study of topical cyclosporin for hypertrophic lichen planus. J Dermatol Treatment 1989; 1:39–41

    Article  Google Scholar 

Download references

Authors
  1. M. Matucci Cerinic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Pignone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Cagnoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Ferranti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. De Pità
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of Florence, 37, via Alfani, 50121, Florence, Italy

    Torello M. Lotti M.D.

  2. 1819 J.F. Kennedy Boulevard Suite 465, 19103, Philadelphia, PA, USA

    Lawrence Charles Parish M.D., F.A.C.P

  3. Department of Dermatology, Mayo Clinic, 200 First Street SW, 55905-0001, MN, Rochester, USA

    Roy Steele Rogers III M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cerinic, M.M., Pignone, A., Lombardi, A., Cagnoni, M., Ferranti, G., Pità, O.D. (1999). Oral Mucosa Signs of Immune, Autoimmune, and Rheumatic Diseases. In: Lotti, T.M., Parish, L.C., Rogers, R.S. (eds) Oral Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59821-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59821-0_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64138-1

  • Online ISBN: 978-3-642-59821-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation